Hacker News new | past | comments | ask | show | jobs | submit login

Some additional information here: https://www.kubotaholdings.co.jp/en/ir/docs/20201216_EN_eSpe...

Assuming this device is actually legit (I'm skeptical...), it would need e.g. FDA approval to be used in the USA, correct?




There's an interesting paragraph in there:

"myopic defocus is already in use in the US with a contact lens, “MiSight® 1 day” by CooperVision, which is U.S. Food and Drug Administration (FDA) approved to slow the progression of myopia. This product, which uses multifocal contact lens technology, passively stimulates the entire peripheral retina with light myopically defocused by the non-central power of the contact lens. Kubota Glasses technology leverages nanotechnology in its electronic glasses-based device and seeks to reduce the progression of myopia by actively stimulating the retina for shorter periods while maintaining high-quality central vision and not affecting daily activities."

Which seems to indicate the main beneficiaries will be children, to slow the progression of myopia. As it mentions, there are already multi-focal contact lenses used for that purpose.

Since the contacts don't seem to be marketed at adults, I suspect this will be similar.


> leverages nanotechnology

What's the "nanotechnology" they are using, and how would that relate to the device's function?

I'll see if I can find blockchain and machine learning somewhere in there.


They have you covered in other press releases:

"Kubota Vision Demonstrates 3D Imaging Capabilities Using AI on PBOS"




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: